Genomic patterns in the schizophrenia brain

Joon-Yong An,Yujin Kim

DOI: https://doi.org/10.1126/science.ads6781

IF: 56.9

2024-10-11

Science

Abstract:Somatic noncoding mutations likely contribute to schizophrenia development.

What problem does this paper attempt to address?

Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes

Eduardo A. Maury,Attila Jones,Vladimir Seplyarskiy,Thanh Thanh L. Nguyen,Chaggai Rosenbluh,Taejong Bae,Yifan Wang,Alexej Abyzov,Sattar Khoshkhoo,Yasmine Chahine,Sijing Zhao,Sanan Venkatesh,Elise Root,Georgios Voloudakis,Panagiotis Roussos,Brain Somatic Mosaicism Network‡,Peter J. Park,Schahram Akbarian,Kristen Brennand,Steven Reilly,Eunjung A. Lee,Shamil R. Sunyaev,Christopher A. Walsh,Andrew Chess

DOI: https://doi.org/10.1126/science.adq1456

IF: 56.9

2024-10-11

Science

Abstract:Germline mutations modulate the risk of developing schizophrenia (SCZ). Much less is known about the role of mosaic somatic mutations in the context of SCZ. Deep (239×) whole-genome sequencing (WGS) of brain neurons from 61 SCZ cases and 25 controls postmortem identified mutations occurring during prenatal neurogenesis. SCZ cases showed increased somatic variants in open chromatin, with increased mosaic CpG transversions (CpG>GpG) and T>G mutations at transcription factor binding sites (TFBSs) overlapping open chromatin, a result not seen in controls. Some of these variants alter gene expression, including SCZ risk genes and genes involved in neurodevelopment. Although these mutational processes can reflect a difference in factors indirectly involved in disease, increased somatic mutations at developmental TFBSs could also potentially contribute to SCZ.

multidisciplinary sciences
Do Nuclear-Encoded Core Subunits of Mitochondrial Complex I Confer Genetic Susceptibility to Schizophrenia in Han Chinese Populations?

Xiao Li,Wen Zhang,Jinsong Tang,Liwen Tan,Xiong-jian Luo,Xiaogang Chen,Yong-Gang Yao

DOI: https://doi.org/10.1038/srep11076

IF: 4.6

2015-01-01

Scientific Reports

Abstract:Schizophrenia is one of the most prevalent psychiatric disorders with complex genetic etiology. Accumulating evidence suggests that energy metabolism and oxidative stress play important roles in the pathophysiology of schizophrenia. Dysfunction of mitochondrial respiratory chain and altered expression of complex I subunits were frequently reported in schizophrenia. To investigate whether nuclear-encoded core subunit genes of mitochondrial complex I are associated with schizophrenia, we performed a genetic association study in Han Chinese. In total, 46 tag single nucleotide polymorphisms (SNPs) from 7 nuclear-encoded core genes of mitochondrial complex I were genotyped in 918 schizophrenia patients and 1042 healthy controls. We also analyzed these SNPs in a large sample mainly composed of Europeans through using the available GWAS datasets from the Psychiatric Genomics Consortium (PGC). No significant associations were detected between these SNPs and schizophrenia in Han Chinese and the PGC data set. However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction. Taken together, our results suggested that common SNPs in the nuclear-encoded core subunit genes of mitochondrial complex I may not confer genetic susceptibility to schizophrenia.
Mtdna Heteroplasmy in Monozygotic Twins Discordant for Schizophrenia

Hong Li,Rui Bi,Yu Fan,Yong Wu,Yanqing Tang,Zongchang Li,Ying He,Jun Zhou,Jinsong Tang,Xiaogang Chen,Yong-Gang Yao

DOI: https://doi.org/10.1007/s12035-016-9996-x

IF: 5.682

2016-01-01

Molecular Neurobiology

Abstract:Although monozygotic (MZ) twins have theoretically identical nuclear DNA sequences, there may be phenotypic differences between them caused by somatic mutations and epigenetic changes affecting each genome. In this study, we collected eight families of MZ twins discordant for schizophrenia with the aim of investigating the potential role of mitochondrial DNA (mtDNA) heteroplasmy in causing the phenotypic differences between the twin pairs. Next-generation sequencing (NGS) technology was used to screen the whole mitochondrial genome of the twin pairs and their parents. The mtDNA heteroplasmy level was found to be nearly identical between the twin pairs but was distinctly different between each mother and their offspring. These results suggest that the discordance of schizophrenia between MZ twins may not be attributable to the difference in mtDNA heteroplasmy, and the high concordance of mtDNA heteroplasmy between MZ twins may indicate the relatively equal distribution of mtDNA during embryo separation of MZ twins and/or the modulation effect from the same nuclear genetic background. Furthermore, we observed an overrepresentation of heteroplasmy in noncoding regions and an elevated ratio of nonsynonymous heteroplasmy, suggesting the possible effects of a purifying selection in shaping the pattern of mtDNA heteroplasmy.
Mitochondrial Genome Variations and Functional Characterization in Han Chinese Families with Schizophrenia

Rui Bi,Jinsong Tang,Wen Zhang,Xiao Li,Shi-Yi Chen,Dandan Yu,Xiaogang Chen,Yong-Gang Yao

DOI: https://doi.org/10.1016/j.schres.2016.01.011

IF: 4.662

2016-01-01

Schizophrenia Research

Abstract:The relationship between mitochondrial DNA (mtDNA) variants and schizophrenia has been strongly debated. To test whether mtDNA variants are involved in schizophrenia in Han Chinese patients, we sequenced the entire mitochondrial genomes of probands from 11 families with a family history and maternal inheritance pattern of schizophrenia. Besides the haplogroup-specific variants, we found 11 nonsynonymous private variants, one rRNA variant, and one tRNA variant in 5 of 11 probands. Among the nonsynonymous private variants, mutations m.15395 A>G and m.8536 A>G were predicted to be deleterious after web-based searches and in silico program affiliated analysis. Functional characterization further supported the potential pathogenicity of the two variants m.15395 A>G and m.8536 A>G to cause mitochondrial dysfunction at the cellular level. Our results showed that mtDNA variants were actively involved in schizophrenia in some families with maternal inheritance of this disease.
Exploration of cell type–specific somatic mutations in schizophrenia and the impact of maternal immune activation on the somatic mutation profile in the brain

Jianbin Du,Yutaka Nakachi,Yui Murata,Emi Kiyota,Tadafumi Kato,Miki Bundo,Kazuya Iwamoto

DOI: https://doi.org/10.1111/pcn.13640

2024-02-11

Psychiatry and Clinical Neurosciences

Abstract:Aim Schizophrenia (SZ) is a severe psychiatric disorder caused by the interaction of genetic and environmental factors. Although somatic mutations that occur in the brain after fertilization may play an important role in the cause of SZ, their frequencies and patterns in the brains of patients and related animal models have not been well studied. This study aimed to find somatic mutations related to the pathophysiology of SZ. Methods We performed whole‐exome sequencing (WES) of neuronal and nonneuronal nuclei isolated from the postmortem prefrontal cortex of patients with SZ (n = 10) and controls (n = 10). After detecting somatic mutations, we explored the similarities and differences in shared common mutations between two cell types and cell type–specific mutations. We also performed WES of prefrontal cortex samples from an animal model of SZ based on maternal immune activation (MIA) and explored the possible impact of MIA on the patterns of somatic mutations. Results We did not find quantitative differences in somatic mutations but found higher variant allele fractions of neuron‐specific mutations in patients with SZ. In the mouse model, we found a larger variation in the number of somatic mutations in the offspring of MIA mice, with the occurrence of somatic mutations in neurodevelopment‐related genes. Conclusion Somatic mutations occurring at an earlier stage of brain cell differentiation toward neurons may be important for the cause of SZ. MIA may affect somatic mutation profiles in the brain.

neurosciences,psychiatry,clinical neurology
Whole-genome Sequencing of Monozygotic Twins Discordant for Schizophrenia Indicates Multiple Genetic Risk Factors for Schizophrenia.

Jinsong Tang,Yu Fan,Hong Li,Qun Xiang,Deng-Feng Zhang,Zongchang Li,Ying He,Yanhui Liao,Ya Wang,Fan He,Fengyu Zhang,Yin Yao Shugart,Chunyu Liu,Yanqing Tang,Raymond C K Chan,Chuan-Yue Wang,Yong-Gang Yao,Xiaogang Chen

DOI: https://doi.org/10.1016/j.jgg.2017.05.005

2017-01-01

Abstract:Schizophrenia is a common disorder with a high heritability, but its genetic architecture is still elusive. We implemented whole-genome sequencing (WGS) analysis of 8 families with monozygotic (MZ) twin pairs discordant for schizophrenia to assess potential association of de novo mutations (DNMs) or inherited variants with susceptibility to schizophrenia. Eight non-synonymous DNMs (including one splicing site) were identified and shared by twins, which were either located in previously reported schizophrenia risk genes (p.V24689I mutation in TTN, p.S2506T mutation in GCN1L1, IVS3+1G > T in DOCK1) or had a benign to damaging effect according to in silico prediction analysis. By searching the inherited rare damaging or loss-of-function (LOF) variants and common susceptible alleles from three classes of schizophrenia candidate genes, we were able to distill genetic alterations in several schizophrenia risk genes, including GAD1, PLXNA2, RELN and FEZ1. Four inherited copy number variations (CNVs; including a large deletion at 16p13.11) implicated for schizophrenia were identified in four families, respectively. Most of families carried both missense DNMs and inherited risk variants, which might suggest that DNMs, inherited rare damaging variants and common risk alleles together conferred to schizophrenia susceptibility. Our results support that schizophrenia is caused by a combination of multiple genetic factors, with each DNM/variant showing a relatively small effect size.
Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network

Michael J. McConnell,John V. Moran,Alexej Abyzov,Schahram Akbarian,Taejeong Bae,Isidro Cortes-Ciriano,Jennifer A. Erwin,Liana Fasching,Diane A. Flasch,Donald Freed,Javier Ganz,Andrew E. Jaffe,Kenneth Y. Kwan,Minseok Kwon,Michael A. Lodato,Ryan E. Mills,Apua C. M. Paquola,Rachel E. Rodin,Chaggai Rosenbluh,Nenad Sestan,Maxwell A. Sherman,Joo Heon Shin,Saera Song,Richard E. Straub,Jeremy Thorpe,Daniel R. Weinberger,Alexander E. Urban,Bo Zhou,Fred H. Gage,Thomas Lehner,Geetha Senthil,Christopher A. Walsh,Andrew Chess,Eric Courchesne,Joseph G. Gleeson,Jeffrey M. Kidd,Peter J. Park,Jonathan Pevsner,Flora M. Vaccarino,Alison R. Barton,Stefan Bekiranov,Craig L. Bohrson,Ian E. Burbulis,William Chronister,Gianfilippo Coppola,Kenneth Daily,Alissa M. D’Gama,Sarah B. Emery,Trenton J. Frisbie,Tianliuyun Gao,Attila Gulyás-Kovács,Mark Haakenson,Jason M. Keil,Huira C. Kopera,Mandy M. Lam,Eunjung Alice Lee,Tomas Marques-Bonet,Gary W. Mathern,John B. Moldovan,Matthew T. Oetjens,Larsson Omberg,Mette A. Peters,Sirisha Pochareddy,Tiziano Pramparo,Aakrosh Ratan,Tiziana Sanavia,Lei Shi,Mario Skarica,Jia Wang,Meiyan Wang,Yifan Wang,Margaret Wierman,Matthew Wolpert,Mollie Woodworth,Xuefang Zhao,Weichen Zhou,

DOI: https://doi.org/10.1126/science.aal1641

IF: 56.9

2017-04-28

Science

Abstract:Single-cell diversity in the brain The cells that make up an organism may all start from one genome, but somatic mutations mean that somewhere along the line of development, an organism's individual cellular genomes diverge. McConnell et al. review the implications and causes of single-cell genomic diversity for brain function. Somatic mutations caused by mobile genetic elements or errors in DNA repair may underlie certain neuropsychiatric disorders. Science , this issue p. eaal1641

multidisciplinary sciences
The Contribution of Mosaic Chromosomal Alterations to Schizophrenia

Kaihui Chang,Xuemin Jian,Chuanhong Wu,Chengwen Gao,Yafang Li,Jianhua Chen,Baiqiang Xue,Yonghe Ding,Lixia Peng,Baokun Wang,Lin He,Yifeng Xu,Changgui Li,Xingwang Li,Zhuo Wang,Xiangzhong Zhao,Dun Pan,Qiangzhen Yang,Juan Zhou,Zijia Zhu

DOI: https://doi.org/10.1016/j.biopsych.2024.06.015

IF: 12.81

2024-01-01

Biological Psychiatry

Abstract:Background Mosaic chromosomal alterations (mCAs) are implicated in neuropsychiatric disorders, yet the contribution to schizophrenia (SCZ) risk for somatic copy number variations (sCNVs) emerging in early developmental stages is not fully established. Methods We analyzed blood-derived genotype arrays from 9,715 SCZ patients and 28,822 controls of Chinese descent using a computational tool (MoChA) based on long-range chromosomal information to detect mCAs. We focused on probable early developmental sCNVs through stringent filtering. We assessed the sCNVs' burden across varying cell fraction (CF) cutoffs, as well as the frequency with which genes were involved in sCNVs. We integrated this data with the Psychiatric Genomics Consortium (PGC) dataset, which comprises 12,834 SCZ cases and 11,648 controls of European descent, and complemented it with genotyping data from postmortem brain tissue of 936 subjects (449 cases and 487 controls). Results Patients with SCZ had a significantly higher somatic losses detection rate than control subjects (1.00% vs 0.52%; odds ratio (OR) = 1.91; 95% CI, 1.47-2.49; two-sided Fisher’s exact test, p=1.49×10-6). Further analysis indicated that the ORs escalated proportionately (from 1.91 to 2.78) with the increment in CF cutoffs. Recurrent sCNVs associated with SCZ (OR>8; Fisher’s exact test, p<0.05) were identified, including notable regions at 10q21.1 (ZWINT), 3q26.1 (SLITRK3), 1q31.1 (BRINP3) and 12q21.31-21.32 (MGAT4C and NTS) in the Chinese cohort, some regions validated with PGC data. Cross-tissue validation pinpointed somatic losses at loci like 1p35.3-35.2 and 19p13.3-13.2. Conclusions The study highlights mCAs' significant impact on SCZ, suggesting their pivotal role in the disorder's genetic etiology.
Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations

Jacob D Clarin,Nadia N Bouras,Wen-Jun Gao

DOI: https://doi.org/10.3390/genes15091214

2024-09-17

Abstract:The genetic basis of schizophrenia (SZ) remains elusive despite its characterization as a highly heritable disorder. This incomplete understanding has led to stagnation in therapeutics and treatment, leaving many suffering with insufficient relief from symptoms. However, recent large-cohort genome- and exome-wide association studies have provided insights into the underlying genetic machinery. The scale of these studies allows for the identification of ultra-rare mutations that confer substantial disease risk, guiding clinicians and researchers toward general classes of genes that are central to SZ etiology. One such large-scale collaboration effort by the Schizophrenia Exome Sequencing Meta-Analysis consortium identified ten, high-risk, ultra-rare, protein-truncating variants, providing the clearest picture to date of the dysfunctional gene products that substantially increase risk for SZ. While genetic studies of SZ provide valuable information regarding "what" genes are linked with the disorder, it is an open question as to "when" during brain development these genetic mutations impose deleterious effects. To shed light on this unresolved aspect of SZ etiology, we queried the BrainSpan developmental mRNA expression database for these ten high-risk genes and discovered three general expression trajectories throughout pre- and postnatal brain development. The elusiveness of SZ etiology, we infer, is not only borne out of the genetic heterogeneity across clinical cases, but also in our incomplete understanding of how genetic mutations perturb neurodevelopment during multiple critical periods. We contextualize this notion within the National Institute of Mental Health's Research Domain Criteria framework and emphasize the utility of considering both genetic variables and developmental context in future studies.
Failure to Identify Somatic Mutations in Monozygotic Twins Discordant for Schizophrenia by Whole Exome Sequencing.

Nan Lyu,Lili Guan,Hong Ma,Xijin Wang,Bao-Ming Wu,Fan-Hong Shang,Dan Wang,Hong Wen,Xin Yu

DOI: https://doi.org/10.4103/0366-6999.178009

IF: 6.133

2016-01-01

Chinese Medical Journal

Abstract:Background: Schizophrenia (SCZ) is a severe, debilitating, and complex psychiatric disorder with multiple causative factors. An increasing number of studies have determined that rare variations play an important role in its etiology. A somatic mutation is a rare form of genetic variation that occurs at an early stage of embryonic development and is thought to contribute substantially to the development of SCZ. The aim of the study was to explore the novel pathogenic somatic single nucleotide variations (SNVs) and somatic insertions and deletions (indels) of SCZ. Methods: One Chinese family with a monozygotic (MZ) twin pair discordant for SCZ was included. Whole exome sequencing was performed in the co-twin and their parents. Rigorous filtering processes were conducted to prioritize pathogenic somatic variations, and all identified SNVs and indels were further confirmed by Sanger sequencing. Results: One somatic SNV and two somatic indels were identified after rigorous selection processes. However, none was validated by Sanger sequencing. Conclusions: This study is not alone in the failure to identify pathogenic somatic variations in MZ twins, suggesting that exonic somatic variations are extremely rare. Further efforts are warranted to explore the potential genetic mechanism of SCZ.
Shaping the Trans-Scale Properties of Schizophrenia via Cerebral Alterations on Magnetic Resonance Imaging and Single-Nucleotide Polymorphisms of Coding and Non-Coding Regions

Shu-Wan Zhao,Xian Xu,Xian-Yang Wang,Tian-Cai Yan,Yang Cao,Qing-Hong Yan,Kun Chen,Yin-Chuan Jin,Ya-Hong Zhang,Hong Yin,Long-Biao Cui

DOI: https://doi.org/10.3389/fnhum.2021.720239

IF: 3.473

2021-09-09

Frontiers in Human Neuroscience

Abstract:Schizophrenia is a complex mental illness with genetic heterogeneity, which is often accompanied by alterations in brain structure and function. The neurobiological mechanism of schizophrenia associated with heredity remains unknown. Recently, the development of trans-scale and multi-omics methods that integrate gene and imaging information sheds new light on the nature of schizophrenia. In this article, we summarized the results of brain structural and functional changes related to the specific single-nucleotide polymorphisms (SNPs) in the past decade, and the SNPs were divided into non-coding regions and coding regions, respectively. It is hoped that the relationship between SNPs and cerebral alterations can be displayed more clearly and intuitively, so as to provide fresh approaches for the discovery of potential biomarkers and the development of clinical accurate individualized treatment decision-making.

psychology,neurosciences
Somatic mosaicism in the diseased brain

Ivan Y. Iourov,Svetlana G. Vorsanova,Oxana S. Kurinnaia,Sergei I. Kutsev,Yuri B. Yurov

DOI: https://doi.org/10.1186/s13039-022-00624-y

2022-10-22

Molecular Cytogenetics

Abstract:It is hard to believe that all the cells of a human brain share identical genomes. Indeed, single cell genetic studies have demonstrated intercellular genomic variability in the normal and diseased brain. Moreover, there is a growing amount of evidence on the contribution of somatic mosaicism (the presence of genetically different cell populations in the same individual/tissue) to the etiology of brain diseases. However, brain-specific genomic variations are generally overlooked during the research of genetic defects associated with a brain disease. Accordingly, a review of brain-specific somatic mosaicism in disease context seems to be required. Here, we overview gene mutations, copy number variations and chromosome abnormalities (aneuploidy, deletions, duplications and supernumerary rearranged chromosomes) detected in the neural/neuronal cells of the diseased brain. Additionally, chromosome instability in non-cancerous brain diseases is addressed. Finally, theoretical analysis of possible mechanisms for neurodevelopmental and neurodegenerative disorders indicates that a genetic background for formation of somatic (chromosomal) mosaicism in the brain is likely to exist. In total, somatic mosaicism affecting the central nervous system seems to be a mechanism of brain diseases.

genetics & heredity
Comprehensive identification of somatic nucleotide variants in human brain tissue

Yifan Wang,Taejeong Bae,Jeremy Thorpe,Maxwell A. Sherman,Attila G. Jones,Sean Cho,Kenneth Daily,Yanmei Dou,Javier Ganz,Alon Galor,Irene Lobon,Reenal Pattni,Chaggai Rosenbluh,Simone Tomasi,Livia Tomasini,Xiaoxu Yang,Bo Zhou,Schahram Akbarian,Laurel L. Ball,Sara Bizzotto,Sarah B. Emery,Ryan Doan,Liana Fasching,Yeongjun Jang,David Juan,Esther Lizano,Lovelace J. Luquette,John B. Moldovan,Rujuta Narurkar,Matthew T. Oetjens,Rachel E. Rodin,Shobana Sekar,Joo Heon Shin,Eduardo Soriano,Richard E. Straub,Weichen Zhou,Andrew Chess,Joseph G. Gleeson,Tomas Marquès-Bonet,Peter J. Park,Mette A. Peters,Jonathan Pevsner,Christopher A. Walsh,Daniel R. Weinberger,Flora M. Vaccarino,John V. Moran,Alexander E. Urban,Jeffrey M. Kidd,Ryan E. Mills,Alexej Abyzov,

DOI: https://doi.org/10.1186/s13059-021-02285-3

IF: 17.906

2021-03-29

Genome Biology

Abstract:Abstract Background Post-zygotic mutations incurred during DNA replication, DNA repair, and other cellular processes lead to somatic mosaicism. Somatic mosaicism is an established cause of various diseases, including cancers. However, detecting mosaic variants in DNA from non-cancerous somatic tissues poses significant challenges, particularly if the variants only are present in a small fraction of cells. Results Here, the Brain Somatic Mosaicism Network conducts a coordinated, multi-institutional study to examine the ability of existing methods to detect simulated somatic single-nucleotide variants (SNVs) in DNA mixing experiments, generate multiple replicates of whole-genome sequencing data from the dorsolateral prefrontal cortex, other brain regions, dura mater, and dural fibroblasts of a single neurotypical individual, devise strategies to discover somatic SNVs, and apply various approaches to validate somatic SNVs. These efforts lead to the identification of 43 bona fide somatic SNVs that range in variant allele fractions from ~ 0.005 to ~ 0.28. Guided by these results, we devise best practices for calling mosaic SNVs from 250× whole-genome sequencing data in the accessible portion of the human genome that achieve 90% specificity and sensitivity. Finally, we demonstrate that analysis of multiple bulk DNA samples from a single individual allows the reconstruction of early developmental cell lineage trees. Conclusions This study provides a unified set of best practices to detect somatic SNVs in non-cancerous tissues. The data and methods are freely available to the scientific community and should serve as a guide to assess the contributions of somatic SNVs to neuropsychiatric diseases.

genetics & heredity,biotechnology & applied microbiology
Somatic mosaicism and neurodevelopmental disease

Alissa M. D’Gama,Christopher A. Walsh

DOI: https://doi.org/10.1038/s41593-018-0257-3

IF: 25

2018-10-22

Nature Neuroscience

Abstract:Traditionally, we have considered genetic mutations that cause neurodevelopmental diseases to be inherited or de novo germline mutations. Recently, we have come to appreciate the importance of de novo somatic mutations, which occur postzygotically and are thus present in only a subset of the cells of an affected individual. The advent of next-generation sequencing and single-cell sequencing technologies has shown that somatic mutations contribute to normal and abnormal human brain development. Somatic mutations are one important cause of neuronal migration and brain overgrowth disorders, as suggested by visible focal lesions. In addition, somatic mutations contribute to neurodevelopmental diseases without visible lesions, including epileptic encephalopathies, intellectual disability, and autism spectrum disorder, and may contribute to a broad range of neuropsychiatric diseases. Studying somatic mutations provides insight into the mechanisms underlying human brain development and neurodevelopmental diseases and has important implications for diagnosis and treatment.

neurosciences
Chromosomal Conformations and Epigenomic Regulation in Schizophrenia.

Prashanth Rajarajan,Yan Jiang,Bibi S Kassim,Schahram Akbarian

DOI: https://doi.org/10.1016/bs.pmbts.2017.11.022

2018-01-01

Progress in Molecular Biology and Translational Science

Abstract:Chromosomal conformations, including promoter-enhancer loops, provide a critical regulatory layer for the transcriptional machinery. Therefore, schizophrenia, a common psychiatric disorder associated with broad changes in neuronal gene expression in prefrontal cortex and other brain regions implicated in psychosis, could be associated with alterations in higher-order chromatin. Here, we review early studies on spatial genome organization in the schizophrenia postmortem brain and discuss how integrative approaches using cell culture and animal model systems could gain deeper insight into the potential roles of higher-order chromatin for the neurobiology of and novel treatment avenues for common psychiatric disease.
Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes

Yong Wu,Xiao-Lin Yu,Xiao Xiao,Ming Li,Yi Li

DOI: https://doi.org/10.1007/s12035-021-02572-x

IF: 5.682

2021-10-09

Molecular Neurobiology

Abstract:Genome-wide association studies (GWAS) have identified a large number of schizophrenia risk variants, and most of them are mapped to noncoding regions. By leveraging multiple joint-tissue gene expression data and GWAS data, we herein performed a transcriptome-wide association study (TWAS) and Mendelian randomization (MR) analysis and identified 144 genes whose mRNA levels were related to genetic risk of schizophrenia. Most of these genes exhibited diametrically opposite trends of expression in prenatal and postnatal brain tissues, despite that their expression levels in dorsolateral prefrontal cortex (DLPFC) tissues did not significantly differ between schizophrenics and healthy controls. We then found significant enrichment of these genes in dopamine-related pathways that were repeatedly implicated in schizophrenia pathogenesis and in the action of antipsychotic drugs. Gene expression analysis using single cell RNA-sequencing (scRNA-seq) data of mid-gestation fetal brains further revealed enrichment of these genes in glutamatergic excitatory neurons and cycling progenitors. These lines of evidence, in consistency with previous findings, confirmed the polygenic nature of schizophrenia and highlighted involvement of early neurodevelopment aberrations in this disorder. Further investigations using advanced algorithms in both bulk brain tissues and in single cells and at different developmental stages are necessary to characterize transcriptomic features of schizophrenia pathogenesis along brain development.

neurosciences
Prevalence and mechanisms of somatic deletions in single human neurons during normal aging and in DNA repair disorders

Junho Kim,August Yue Huang,Shelby L. Johnson,Jenny Lai,Laura Isacco,Ailsa M. Jeffries,Michael B. Miller,Michael A. Lodato,Christopher A. Walsh,Eunjung Alice Lee

DOI: https://doi.org/10.1038/s41467-022-33642-w

IF: 16.6

2022-10-08

Nature Communications

Abstract:Replication errors and various genotoxins cause DNA double-strand breaks (DSBs) where error-prone repair creates genomic mutations, most frequently focal deletions, and defective repair may lead to neurodegeneration. Despite its pathophysiological importance, the extent to which faulty DSB repair alters the genome, and the mechanisms by which mutations arise, have not been systematically examined reflecting ineffective methods. Here, we develop PhaseDel, a computational method to detect focal deletions and characterize underlying mechanisms in single-cell whole genome sequences (scWGS). We analyzed high-coverage scWGS of 107 single neurons from 18 neurotypical individuals of various ages, and found that somatic deletions increased with age and in highly expressed genes in human brain. Our analysis of 50 single neurons from DNA repair-deficient diseases with progressive neurodegeneration (Cockayne syndrome, Xeroderma pigmentosum, and Ataxia telangiectasia) reveals elevated somatic deletions compared to age-matched controls. Distinctive mechanistic signatures and transcriptional associations suggest roles for somatic deletions in neurodegeneration.

multidisciplinary sciences
A polygenic burden of rare disruptive mutations in schizophrenia

Shaun M. Purcell,Jennifer L. Moran,Menachem Fromer,Douglas Ruderfer,Nadia Solovieff,Panos Roussos,Colm O’Dushlaine,Kimberly Chambert,Sarah E. Bergen,Anna Kähler,Laramie Duncan,Eli Stahl,Giulio Genovese,Esperanza Fernández,Mark O. Collins,Noboru H. Komiyama,Jyoti S. Choudhary,Patrik K. E. Magnusson,Eric Banks,Khalid Shakir,Kiran Garimella,Tim Fennell,Mark DePristo,Seth G. N. Grant,Stephen J. Haggarty,Stacey Gabriel,Edward M. Scolnick,Eric S. Lander,Christina M. Hultman,Patrick F. Sullivan,Steven A. McCarroll,Pamela Sklar

DOI: https://doi.org/10.1038/nature12975

IF: 64.8

2014-01-22

Nature

Abstract:Schizophrenia is a common disease with a complex aetiology, probably involving multiple and heterogeneous genetic factors. Here, by analysing the exome sequences of 2,536 schizophrenia cases and 2,543 controls, we demonstrate a polygenic burden primarily arising from rare (less than 1 in 10,000), disruptive mutations distributed across many genes. Particularly enriched gene sets include the voltage-gated calcium ion channel and the signalling complex formed by the activity-regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, sets previously implicated by genome-wide association and copy-number variation studies. Similar to reports in autism, targets of the fragile X mental retardation protein (FMRP, product of FMR1) are enriched for case mutations. No individual gene-based test achieves significance after correction for multiple testing and we do not detect any alleles of moderately low frequency (approximately 0.5 to 1 per cent) and moderately large effect. Taken together, these data suggest that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.

multidisciplinary sciences
Schizophrenia genomics: genetic complexity and functional insights

Patrick F. Sullivan,Shuyang Yao,Jens Hjerling-Leffler

DOI: https://doi.org/10.1038/s41583-024-00837-7

IF: 38.755

2024-07-20

Nature Reviews Neuroscience

Abstract:Determining the causes of schizophrenia has been a notoriously intractable problem, resistant to a multitude of investigative approaches over centuries. In recent decades, genomic studies have delivered hundreds of robust findings that implicate nearly 300 common genetic variants (via genome-wide association studies) and more than 20 rare variants (via whole-exome sequencing and copy number variant studies) as risk factors for schizophrenia. In parallel, functional genomic and neurobiological studies have provided exceptionally detailed information about the cellular composition of the brain and its interconnections in neurotypical individuals and, increasingly, in those with schizophrenia. Taken together, these results suggest unexpected complexity in the mechanisms that drive schizophrenia, pointing to the involvement of ensembles of genes (polygenicity) rather than single-gene causation. In this Review, we describe what we now know about the genetics of schizophrenia and consider the neurobiological implications of this information.

neurosciences
Mutation burden of rare variants in schizophrenia candidate genes

Simon L Girard,Patrick A Dion,Cynthia V Bourassa,Steve Geoffroy,Pamela Lachance-Touchette,Amina Barhdadi,Mathieu Langlois,Ridha Joober,Marie-Odile Krebs,Marie-Pierre Dubé,Guy A Rouleau

DOI: https://doi.org/10.1371/journal.pone.0128988

IF: 3.7

2015-06-03

PLoS ONE

Abstract:Background: Schizophrenia (SCZ) is a very heterogeneous disease that affects approximately 1% of the general population. Recently, the genetic complexity thought to underlie this condition was further supported by three independent studies that identified an increased number of damaging de novo mutations DNM in different SCZ probands. While these three reports support the implication of DNM in the pathogenesis of SCZ, the absence of overlap in the genes identified suggests that the number of genes involved in SCZ is likely to be very large; a notion that has been supported by the moderate success of Genome-Wide Association Studies (GWAS). Methods: To further examine the genetic heterogeneity of this disease, we resequenced 62 genes that were found to have a DNM in SCZ patients, and 40 genes that encode for proteins known to interact with the products of the genes with DNM, in a cohort of 235 SCZ cases and 233 controls. Results: We found an enrichment of private nonsense mutations amongst schizophrenia patients. Using a kernel association method, we were able to assess for association for different sets. Although our power of detection was limited, we observed an increased mutation burden in the genes that have DNM.

Genomic patterns in the schizophrenia brain

Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes

Do Nuclear-Encoded Core Subunits of Mitochondrial Complex I Confer Genetic Susceptibility to Schizophrenia in Han Chinese Populations?

Mtdna Heteroplasmy in Monozygotic Twins Discordant for Schizophrenia

Mitochondrial Genome Variations and Functional Characterization in Han Chinese Families with Schizophrenia

Exploration of cell type–specific somatic mutations in schizophrenia and the impact of maternal immune activation on the somatic mutation profile in the brain

Whole-genome Sequencing of Monozygotic Twins Discordant for Schizophrenia Indicates Multiple Genetic Risk Factors for Schizophrenia.

Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network

The Contribution of Mosaic Chromosomal Alterations to Schizophrenia

Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations

Failure to Identify Somatic Mutations in Monozygotic Twins Discordant for Schizophrenia by Whole Exome Sequencing.

Shaping the Trans-Scale Properties of Schizophrenia via Cerebral Alterations on Magnetic Resonance Imaging and Single-Nucleotide Polymorphisms of Coding and Non-Coding Regions

Somatic mosaicism in the diseased brain

Comprehensive identification of somatic nucleotide variants in human brain tissue

Somatic mosaicism and neurodevelopmental disease

Chromosomal Conformations and Epigenomic Regulation in Schizophrenia.

Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes

Prevalence and mechanisms of somatic deletions in single human neurons during normal aging and in DNA repair disorders

A polygenic burden of rare disruptive mutations in schizophrenia

Schizophrenia genomics: genetic complexity and functional insights

Mutation burden of rare variants in schizophrenia candidate genes